To further develop various research areas and to refine the journal’s scope, Bioengineering (ISSN: 2306-5354) is recruiting a Section Editor-in-Chief for the Section “Cellular and Molecular Bioengineering”.
The main responsibilities of the Section Editor-in-Chief include the following:
- Acting as an ambassador for the journal, MDPI, and open access publishing;
- Scientific decisions about the scope of their section;
- Inviting distinguished scientists to join the Editorial Board;
- Suggesting topics for Special Issues;
- Providing support and guidance to Editorial Board Members and Editorial Staff where required;
- Maintaining oversight of the editorial process for individual manuscripts in their section (mainly by making the final decision regarding whether or not a paper can be published after peer review and revisions);
- Understanding, leading, and upholding MDPI’s peer review and ethics guidelines.
This position is open to experts on related aspects of cellular and molecular bioengineering and will remain open until the journal formally announces the Section Editor-in-Chief online. To apply for this position, recommend potential candidates, or request further information, please contact the Bioengineering Editorial Office or the Section Managing Editor, Ms. Winni Liu (winni.liu@mdpi.com).
Bioengineering is an international, scientific, peer-reviewed, open access journal on the science and technology of bioengineering, published monthly online by MDPI, Basel, Switzerland. This journal provides an advanced forum for the exchange of research on the science and technology of bioengineering. It publishes original research papers, comprehensive reviews, and communications. Our aim is to encourage scientists to publish their experimental and theoretical results in as much detail as possible. All aspects of bioengineering are welcome, from theoretical concepts to applications. The journal has been indexed in Scopus, Science Citation Index Expanded (SCIE: Web of Science), PubMed, PMC, CAPlus/SciFinder, Inspec, and other databases. The Impact Factor for Bioengineering (2023) is 3.8, ranking Q2 in the “Engineering, Biomedical” category.
